IDV vehicle
75N94020D00012
AWARD IDIQ FOR THE CONTRACEPTIVE CLINICAL TRIALS NETWORK FEMALE SITES TO PERFORM PHASE I, II, III, AND PHASE IV CLINICAL TRIALS OF A WIDE VARIETY OF NEW OR EXISTING FEMALE CONTRACEPTIVE METHODS.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NICHD |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $0 |
| Current contract value | Not reported |
| Potential contract value / ceiling | $5.0M |
| Start date | Aug 8, 2020 |
| Current end date | Not available |
| Potential end date | Not available |
| Latest award activity | Jul 24, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 24, 2026 | P00003 | $0 | EO14398 NICHD:R&D:AWARD IDIQ FOR THE CONTRACEPTIVE CLINICAL TRIALS NETWORK FEMALE SITES TO PERFORM PHASE I, II, III, AND PHASE IV CLINICAL TRIALS OF A W THIS FAR CLAUSE WILL APPLY TO ALL EXISTING AND FUTURE TASK/DELIVERY ORDERS UNDER THIS CO |
| Jun 16, 2022 | P00002 | $0 | IPP- THIS FAR CLAUSE WILL APPLY TO ALL EXISTING AND FUTURE TASK/DELIVERY ORDERS UNDER THIS CONTRACT. |
| Nov 23, 2021 | P00001 | $0 | EO14042 THE PURPOSE OF THIS MODIFICATION IS TO INCLUDE FAR CLAUSE DEVIATION CLAUSE 52.223-99 ENSURING ADEQUATE COVID-19 SAFETY PROTOCOLS FOR FEDERAL CONTRACTORS PURSUANT WITH EXECUTIVE ORDER 14042. THIS FAR CLAUSE WILL APPLY TO ALL EXISTING AND |
| Aug 6, 2020 | 0 | $0 | AWARD IDIQ FOR THE CONTRACEPTIVE CLINICAL TRIALS NETWORK FEMALE SITES TO PERFORM PHASE I, II, III, AND PHASE IV CLINICAL TRIALS OF A WIDE VARIETY OF NEW OR EXISTING FEMALE CONTRACEPTIVE METHODS. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.